MedTrace Logo

Investigating Different Anticoagulants for Renal Replacement Therapy

NCT02669589 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 638

Last updated 2020-02-19

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of regional citrate anticoagulation within the scope of continuous renal replacement (CRRT) in critically ill patients with acute kidney injury (AKI) on filter life span and 90-day all cause mortality.

Conditions

Interventions

DRUG

Heparin

DRUG

Citrate

Sponsors & Collaborators

  • University of Leipzig

    collaborator OTHER

  • German Research Foundation

    collaborator OTHER

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Alexander Zarbock, MD · University Hospital Muenster

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2019-04-03
Completion
2020-01-03

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02669589 on ClinicalTrials.gov